PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-III FUTURE 5 study

Novartis Receives EU Approval for Cosentyx's (secukinumab) Label Update in Patients with Psoriatic Arthritis (PsA)

Novartis Receives EU Approval for Cosentyx's (secukinumab) Label Update in Patients with Psoriatic Arthritis (PsA)

October 26, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us